QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
OTCMKTS:MRMD

MariMed Stock Forecast, Price & News

$0.75
-0.10 (-11.76 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.65
Now: $0.75▼
$0.85
50-Day Range
$0.31
MA: $0.55▼
$0.90
52-Week Range
$0.10
Now: $0.75▼
$0.94
Volume4.96 million shs
Average Volume4.86 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MariMed Inc. provides consulting services for the design, development, operation, management, and optimization of medical cannabis cultivation, production, and dispensary facilities. It also develops and manages facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis, and cannabis-infused products under the Kalm Fusion, Betty's Eddies, and Nature's Heritage brand name. In addition, the company offers regulatory, accounting, human resources, and administrative services. It has secured 13 cannabis licenses for clients in Delaware, Illinois, Nevada, Rhode Island, Massachusetts, and Maryland. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MarketRank™

Overall MarketRank™

0.80 out of 5 stars

Technology Services Sector

3rd out of 23 stocks

Packaged Software Industry

3rd out of 13 stocks

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Packaged Software
Sub-IndustryN/A
SectorTechnology Services
Current SymbolOTCMKTS:MRMD
Previous Symbol
CUSIPN/A
CIKN/A
Webmarimedadvisors.com
Phone(844) 244-0200
Employees81
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
$0.75
-0.10 (-11.76 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for MRMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MariMed (OTCMKTS:MRMD) Frequently Asked Questions

How has MariMed's stock been impacted by COVID-19?

MariMed's stock was trading at $0.1599 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MRMD stock has increased by 369.0% and is now trading at $0.75.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than MariMed?

Wall Street analysts have given MariMed a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MariMed wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) posted its quarterly earnings results on Monday, November, 9th. The company reported $0.01 EPS for the quarter. The firm earned $13.46 million during the quarter.
View MariMed's earnings history.

Are investors shorting MariMed?

MariMed saw a decrease in short interest in December. As of December 31st, there was short interest totaling 580,000 shares, a decrease of 62.5% from the December 15th total of 1,547,500 shares. Based on an average trading volume of 4,194,200 shares, the short-interest ratio is presently 0.1 days.
View MariMed's Short Interest.

Who are some of MariMed's key competitors?

Some companies that are related to MariMed include Cerence (CRNCV), Enghouse Systems (EGHSF), Exxe Group (AXXA), Jamf (JAMF), mCloud Technologies (MCLDD), Source Dividend Opportunity ETF (DVOP), Source Dividend Opportunity ETF (DVOP), Sylogist (SYZLF), Tecsys (TCYSF) and View Systems (VSYM).
View all of MRMD's competitors.

What other stocks do shareholders of MariMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MariMed investors own include KushCo (KSHB), OrganiGram (OGI), Auxly Cannabis Group (CBWTF), Cannabics Pharmaceuticals (CNBX), The Supreme Cannabis (SPRWF), Gran Tierra Energy (GTE), Pennsylvania Real Estate Investment Trust (PEI), GB Sciences (GBLX), Medical Marijuana (MJNA) and Smart Cannabis (SCNA).

Who are MariMed's key executives?

MariMed's management team includes the following people:
  • Mr. Robert N. Fireman, Chairman, Pres & CEO (Age 71, Pay $150k)
  • Mr. Jon R. Levine, CFO, Treasurer, Sec. & Director (Age 55)
  • Mr. Tim Shaw, Chief Operating Officer
  • Mr. Jonathan W. Rider, Chief Information Officer (Age 55)
  • Ms. Sara Gullickson, VP of Marketing (Age 35)
  • Mr. Ryan Crandall, VP of Product & Sales
  • Mr. Charles Holt Finnie, Chief Strategy Officer
  • Dr. Jokubas Ziburkus, Chief Innovation Officer
  • Mr. James E. Griffin, Advisor

What is MariMed's stock symbol?

MariMed trades on the OTCMKTS under the ticker symbol "MRMD."

How do I buy shares of MariMed?

Shares of MRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MariMed's stock price today?

One share of MRMD stock can currently be purchased for approximately $0.75.

What is MariMed's official website?

The official website for MariMed is marimedadvisors.com.

How can I contact MariMed?

The company can be reached via phone at (844) 244-0200.

This page was last updated on 1/26/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.